cancer

Chemoradiotherapy with Concurrent Durvalumab for the Palliative Treatment of Oligometastatic Oesophageal and Gastrooesophageal Carcinoma with Dysphagia: A Single Arm Phase II Clinical Trial (PALEO, Sponsored by the Australasian Gastro-Intestinal Trials Group)
Convergent and Criterion Validity of PROMIS Anxiety Measures Relative to Six Legacy Measures and a Structured Diagnostic Interview for Anxiety in Cancer Patients
Assessing the Impact of Magnetic Resonance Treatment Simulation (MRSIM) on Target Volume Delineation and Dose to Organs at Risk for Oropharyngeal Radiotherapy
Percentage Grade 4 Tumour Predicts Outcome for Prostate Adenocarcinoma in Needle Biopsies from Patients with Advanced Disease: 10-Year Data from the TROG 03.04 RADAR Trial
CD36 Polymorphisms and the Age of Disease Onset in Patients with Pathogenic Variants within the Mutation Cluster Region of APC
The Neurotrophic Tyrosine Kinase Receptor 1 (TrkA) Is Overexpressed in Oesophageal Squamous Cell Carcinoma
The Receptor Tyrosine Kinase Trka Is Increased and Targetable in HER2-Positive Breast Cancer
Perineural Invasion by Prostate Adenocarcinoma in Needle Biopsies Predicts Bone Metastasis: Ten Year Data from the TROG 03.04 RADAR Trial